Jim has significant experience litigating patent cases on behalf of plaintiffs and defendants across various technologies. He is the Co-Chair of the firm’s Pharmaceutical & Life Sciences Practice focused on representing generic pharmaceutical companies in Hatch Waxman litigation. Jim also has considerable experience in the biotech area litigating cases involving DNA microarrays, labeling reagents, and immunochemical detection systems. In the electrical engineering and computer science area, he regularly leads cases concerning all aspects of this technology, including redirection software, laptop computers, and mobile phones.

Jim’s practice is international in scope. He has litigated in courts across the country, and in international arbitrations in Switzerland and Germany. He has significant experience in popular patent forums, including Delaware, New Jersey, the Eastern District of Texas, the Western District of Wisconsin, the Northern District of California, the District of Nevada, the ITC, and the PTAB.

In the transactional area, Jim’s experience includes advising investment banks, private equity firms, and corporations on the intellectual property aspects of mergers, acquisitions, and other corporate transactions. As part of this transactional work, he has reviewed patent portfolios as well as outstanding patent litigations and other intellectual property in connection with mergers and acquisitions.

Jim has over 20 years of experience in patent litigation and is admitted to the Patent Bar. Prior to joining Kramer Alberti, Jim worked at firms including WilmerHale and Latham & Watkins as a patent litigator.